Positional scanning substrate combinatorial library (PS-SCL) approach to define caspase substrate specificity

Methods in Molecular Biology

Volumn 1133, Issue , 2014, Pages 41-59

  Porȩba, Marcin ^a   Szalek, Aleksandra ^a   Kasperkiewicz, Paulina ^a   Dra̧g, Marcin ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Caspase; Combinatorial library; Cysteine protease; Fluorogenic substrate; Substrate specificity

Indexed keywords

CASPASE; CASPASE 10; CASPASE 14; CASPASE 2; CASPASE 3; CASPASE 4; CASPASE 5; CASPASE 6; CASPASE 7; CASPASE 8; CASPASE 9; INTERLEUKIN 1BETA CONVERTING ENZYME; TETRAPEPTIDE; PEPTIDE; RESIN;

ARTICLE; COMBINATORIAL CHEMISTRY; ENZYME ACTIVITY; ENZYME KINETICS; ENZYME PURIFICATION; ENZYME SPECIFICITY; ENZYME SUBSTRATE COMPLEX; ENZYME SYNTHESIS; FLUORESCENCE; HUMAN; POSITIONAL SCANNING SUBSTRATE COMBINATORIAL LIBRARY APPROACH; PRIORITY JOURNAL; SOLID PHASE SYNTHESIS; COMBINATORIAL LIBRARY; CONJUGATION; KINETICS; PURIFICATION; SYNTHESIS;

EID: 84958763403     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-357-3_2     Document Type: Article

References (36)

1. Drag M, Salvesen GS (2010) Emerging principles in protease-based drug discovery. Nat Rev Drug Discov 9(9):690-701. doi: 10.1038/nrd3053
2. Fuentes-Prior P, Salvesen GS (2004) The protein structures that shape caspase activity, specifi city, activation and inhibition. Biochem J 384(Pt 2):201-232. doi: 10.1042/BJ20041142
3. Salvesen GS, Dixit VM (1997) Caspases: intracellular signaling by proteolysis. Cell 91(4): 443-446
4. Pop C, Salvesen GS (2009) Human caspases: activation, specifi city, and regulation. J Biol Chem 284(33):21777-21781. doi: 10.1074/jbc.R800084200 , R800084200
5. Thornberry NA, Lazebnik Y (1998) Caspases: enemies within. Science 281(5381):1312-1316
6. Poreba M, Drag M (2010) Current strategies for probing substrate specifi city of proteases. Curr Med Chem 17(33):3968-3995
7. Ostresh JM, Winkle JH, Hamashin VT et al (1994) Peptide libraries: determination of relative reaction rates of protected amino acids in competitive couplings. Biopolymers 34(12): 1681-1689. doi: 10.1002/bip.360341212
8. Rano TA, Timkey T, Peterson EP et al (1997) A combinatorial approach for determining protease specifi cities: application to interleukin-1beta converting enzyme (ICE). Chem Biol4(2):149-155, S1074-5521(97)90258-1 [pii]
9. Sleath PR, Hendrickson RC, Kronheim SR et al (1990) Substrate specifi city of the protease that processes human interleukin-1 beta. J Biol Chem 265(24):14526-14528
10. Howard AD, Kostura MJ, Thornberry N et al (1991) IL-1-converting enzyme requires aspartic acid residues for processing of the IL-1 beta precursor at two distinct sites and does not cleave 31-kDa IL-1 alpha. J Immunol 147(9): 2964-2969
11. Thornberry NA, Bull HG, Calaycay JR et al (1992) A novel heterodimeric cysteine protease is required for interleukin-1 beta processing in monocytes. Nature 356(6372):768-774. doi:10.1038/356768a0
12. Thornberry NA, Molineaux SM (1995) Interleukin-1 beta converting enzyme: a novel cysteine protease required for IL-1 beta production and implicated in programmed cell death. Protein Sci 4(1):3-12. doi: 10.1002/pro. 5560040102
13. Thornberry NA, Rano TA, Peterson EP et al (1997) A combinatorial approach defi nes specifi cities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis. J Biol Chem 272(29):17907-17911
14. Garcia-Calvo M, Peterson EP, Rasper DM et al (1999) Purifi cation and catalytic properties of human caspase family members. Cell Death Differ 6(4):362-369. doi: 10.1038/sj. cdd.4400497
15. Wachmann K, Pop C, van Raam BJ et al (2010) Activation and specifi city of human caspase-10. Biochemistry 49(38):8307-8315.doi: 10.1021/bi100968m
16. Mikolajczyk J, Scott FL, Krajewski S et al (2004) Activation and substrate specifi city of caspase-14. Biochemistry 43(32):10560-10569. doi: 10.1021/bi0498048
17. Edwards PD, Mauger RC, Cottrell KM et al (2000) Synthesis and enzymatic evaluation of P1 arginine aminocoumarin substrate library for trypsin-like serine proteases. Bioorg Med Chem Lett 10(20):2291-2294
18. Backes BJ, Harris JL, Leonetti F et al (2000) Synthesis of positional-scanning libraries of fl uorogenic peptide substrates to defi ne the extended substrate specifi city of plasmin and thrombin. Nat Biotechnol 18(2):187-193. doi: 10.1038/72642
19. Harris JL, Backes BJ, Leonetti F et al (2000) Rapid and general profi ling of protease specifi city by using combinatorial fl uorogenic substrate libraries. Proc Natl Acad Sci U S A 97(14):7754-7759. doi: 10.1073/pnas. 140132697 , 140132697 [pii]
20. Maly DJ, Leonetti F, Backes BJ et al (2002) Expedient solid-phase synthesis of fl uorogenic protease substrates using the 7-amino-4- carbamoylmethylcoumarin (ACC) fl uorophore. J Org Chem 67(3):910-915, jo016140o [pii]
21. Walters J, Pop C, Scott FL et al (2009) A constitutively active and uninhibitable caspase-3 zymogen effi ciently induces apoptosis. Biochem J 424(3):335-345. doi: 10.1042/BJ20090825
22. Choe Y, Leonetti F, Greenbaum DC et al (2006) Substrate profi ling of cysteine proteases using a combinatorial peptide library identify es functionally unique specifi cities. J Biol Chem 281(18):12824-12832. doi: 10.1074/jbc.M513331200
23. Debela M, Magdolen V, Schechter N et al (2006) Specifi city profi ling of seven human tissue kallikreins reveals individual subsite preferences. J Biol Chem 281(35):25678-25688. d o i : 1 0 . 1 0 7 4 / j b c . M 6 0 2 3 7 2 2 0 0 , M602372200 [pii]
24. Hachmann J, Snipas SJ, van Raam BJ et al (2012) Mechanism and specifi city of the human paracaspase MALT1. Biochem J 443(1): 287-295. doi: 10.1042/BJ20120035
25. Drag M, Mikolajczyk J, Bekes M et al (2008) Positional-scanning fl uorigenic substrate libraries reveal unexpected specifi city determinants of DUBs (deubiquitinating enzymes). Biochem J 415(3):367-375. doi: 10.1042/BJ20080779 , BJ20080779 [pii]
26. Garcia-Calvo M, Peterson EP, Leiting B et al (1998) Inhibition of human caspases by peptide- based and macromolecular inhibitors. J Biol Chem 273(49):32608-32613
27. Stennicke HR, Salvesen GS (1999) Caspases: preparation and characterization. Methods 17(4):313-319. doi: 10.1006/meth.1999.0745
28. Ekici OD, Li ZZ, Campbell AJ et al (2006) Design, synthesis, and evaluation of aza- peptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10. J Med Chem 49(19):5728-5749. doi: 10.1021/jm0601405
29. Fu J, Yang Y, Zhang XW et al (2010) Discovery of 1H-benzo[d][1,2,3] triazol-1-yl 3,4,5-trimethoxybenzoate as a potential antiproliferative agent by inhibiting histone deacetylase. Bioorg Med Chem 18(24):8457-8462.doi: 10.1016/j.bmc.2010.10.049
30. Carpino LA, Han GY (1972) 9-Fluorenylmethoxycarbonyl amino- protecting group. J Org Chem 37(22):3404-3409
31. Kaiser E, Colescott RL, Bossinger CD et al (1970) Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides. Anal Biochem 34(2):595-598
32. Chang CD, Meienhofer J (1978) Solid-phase peptide synthesis using mild base cleavage of alpha-fl uorenylmethyloxycarbonylamino acids, exemplifi ed by a synthesis of dihydrosomatostatin. Int J Pept Protein Res 11(3): 246-249
33. Chan WC, White PD (2000) Fmoc solid phase peptide synthesis, the practical approach series. Oxford University Press, New York, pp 1-74
34. Merrifi eld RB (1963) Solid phase peptide synthesis. I. The synthesis of a tetrapeptide. J Am Chem Soc 85(14):2149-2154
35. McStay GP, Salvesen GS, Green DR (2008) Overlapping cleavage motif selectivity of caspases: implications for analysis of apoptotic pathways. Cell Death Differ 15(2):322-331. doi: 10.1038/sj.cdd.4402260
36. Stennicke HR, Salvesen GS (1997) Biochemical characteristics of caspases-3, -6, -7, and -8. J Biol Chem 272(41):25719-25723